ClinicalTrials.gov
ClinicalTrials.gov Menu

Topical Antibiotics and Intravitreous Injections

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00410891
Recruitment Status : Completed
First Posted : December 13, 2006
Results First Posted : June 12, 2014
Last Update Posted : November 6, 2017
Sponsor:
Information provided by (Responsible Party):
Christopher Ta, Stanford University

Brief Summary:
Evaluation of efficacy of topical preoperative antibiotics in patients undergoing intravitreous injections.

Condition or disease Intervention/treatment Phase
Intravitreous Injections Drug: gatifloxacin Phase 4

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 129 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Study Start Date : July 2008
Actual Primary Completion Date : December 2009
Actual Study Completion Date : December 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Antibiotics
U.S. FDA Resources

Arm Intervention/treatment
Experimental: topical antibiotic
topical gatifloxacin 4 times per day
Drug: gatifloxacin



Primary Outcome Measures :
  1. Positive Culture [ Time Frame: Study day 1, assessed following administration of study treatment ]
    The percentage of patients with a positive bacterial culture following administration of study treatment is presented.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • intravitreous injection

Exclusion Criteria:

  • antibiotic use

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00410891


Locations
United States, California
Stanford
Stanford, California, United States, 94304
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Christopher Ta, MD Stanford University

Responsible Party: Christopher Ta, Principle Investigator, Stanford University
ClinicalTrials.gov Identifier: NCT00410891     History of Changes
Other Study ID Numbers: 96803 (eProtocol 4384)
First Posted: December 13, 2006    Key Record Dates
Results First Posted: June 12, 2014
Last Update Posted: November 6, 2017
Last Verified: October 2017

Additional relevant MeSH terms:
Anti-Bacterial Agents
Gatifloxacin
Anti-Infective Agents
Topoisomerase II Inhibitors
Topoisomerase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Antineoplastic Agents